Hypercoagulability after partial liver resection

Thrombosis and Haemostasis

Volumn 98, Issue 6, 2007, Pages 1252-1256

  Bezeaud, Annie ^a,b   Denninger, Marie Hélène ^a   Dondero, Federica ^a   Saada, Véronique ^a   Venisse, Laurence ^b   Huisse, Marie Geneviève ^b   Belghiti, Jacques ^a   Guillin, Marie Claude ^a,b  

^a BEAUJON HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Donor safety; Hypercoagulability; Living donor liver transplantation; Thrombosis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 7; NADROPARIN; PADGEM PROTEIN; PROTEIN C; THROMBIN ANTITHROMBIN COMPLEX; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; LIVING DONOR; LUNG EMBOLISM; MALE; MORBIDITY; MORTALITY; PORTAL VEIN THROMBOSIS; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION;

ADULT; ANTICOAGULANTS; ANTITHROMBIN III; BIOLOGICAL MARKERS; BLOOD COAGULATION; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; P-SELECTIN; PEPTIDE HYDROLASES; PROSPECTIVE STUDIES; THROMBOPHILIA; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 36949002293     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-03-0221     Document Type: Article

References (23)

1. Beavers KL, Sandler RS, Shrestha R. Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl 2002; 8: 110-117.
2. Brown RS Jr, Russo MW, Lai M, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003; 348: 818825.
3. Broering DC, Wilms C, Bok P, et al. Evolution of donor morbidity in living related liver transplantation: a single-center analysis of 165 cases. Ann Surg 2004; 240: 1013-24; discussion 1024-1026.
4. Lo CM. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers. Transplantation 2003; 75: S12-S15.
5. Middleton PF, Duffield M, Lynch SV, et al. Living donor liver transplantation-adult donor outcomes: a systematic review. Liver Transpl 2006; 12: 2430.
6. Shackleton CR, Vierling JM, Nissen N, et al. Morbidity in live liver donors: standards-based adverse event reporting further refined. Arch Surg 2005; 140: 888-895.
7. Umeshita K, Fujiwara K, Kiyosawa K,et al.Operative morbidity of living liver donors in Japan. Lancet 2003; 362: 687-690.
8. Dondero F, Farges O, Belghiti J, et al. A prospective analysis of living-liver donation shows a high rate of adverse events. J Hepatobiliary Pancreat Surg 2006; 13: 117-122.
9. Durand F, Ettorre GM, Douard R, et al. Donor safety in living related liver transplantation: underestimation of the risks for deep vein thrombosis and pulmonary embolism. Liver Transpl 2002; 8: 118-120.
10. Adam R, McMaster P, O'Grady JG, et al. European Liver Transplant Association. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003; 9: 12311243.
11. Bentabak K, Graba A, Boudjema K, et al. Adult-to-adult living related liver transplantation: preliminary results of the Hepatic Transplantation Group in Algiers. Transplant Proc 2005; 37: 2873-2874.
12. Malago M, Testa G, Frilling A, et al. Right living donor liver transplantation: an option for adult patients: single institution experience with 74 patients. Ann Surg 2003; 238: 853-862.
13. Rudow DL, Brown RS Jr, Emond JC, et al, One-year morbidity after donor right hepatectomy. Liver Transpl 2004; 10: 1428-1431.
14. Cerutti E, Stratta C, Romagnoli R, et al. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl 2004; 10: 289-294.
15. Dondero F, Taille C, Mal H, et al. Respiratory complications: a major concern after right hepatectomy in living liver donors. Transplantation 2006; 81: 181-186.
16. Winn KL, Kelly D, Summerfield JA, et al. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 1985; 317: 726-729.
17. Hollestelle MJ, Thinnes T, Crain K, et al. Tissue distribution of factor VIII gene expression in vivo - a closer look. Thromb Haemost 2001; 86: 855-861.
18. Baruch Y, Neubauer K, Shenkar L, et al. Von Willebrand factor in plasma and in liver tissue after partial hepatectomy in the rat. J Hepatol 2002; 37: 471-477.
19. Hollestelle MJ, Poyck PP, Hollestelle JM, et al. Extra-hepatic factor VIII expression in porcine fulminant hepatic failure. J Thromb Haemost 2005; 3: 2274-2280.
20. Bauersachs R, Alban S. Peri-operative bridging with fondaparinux in a woman with antithrombin deficiency. Thromb Haemost 2007; 97: 498-499.
21. Frenette PS, Johnson RC, Hynes RO, et al. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-Selectin. Proc Natl Acad Sci USA 1995; 92: 7450-7454.
22. Andre P, Hartwell D, Hrachovinova I, et al. Procoagulant state resulting from high levels of soluble P-Selectin in blood. Proc Natl Acad Sci USA 2000; 97: 13835-13840.
23. Kyrle PA, Hron G, Eichinger S, et al. Circulating P-Selectin and the risk of recurrrent venous thromboembolism. Thromb Haemost 2007; 97: 880-883.